Treatment News : Low Vitamin D Hinders CD4 Gains in Women Starting HIV Treatment Late

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » December 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


December 5, 2012

Low Vitamin D Hinders CD4 Gains in Women Starting HIV Treatment Late

Women who start HIV treatment late in the course of their infection gain fewer CD4 cells if they have insufficient vitamin D levels, government scientists have reported in the online edition of AIDS, according to aidsmap. After previous studies found a high prevalence of low vitamin D among people with HIV and also found that these deficiencies hinder CD4 cell increases among men who start treatment late, investigators from the Women’s Interagency HIV Study (WIHS) sought to determine if women experience a similar reaction to the vitamin deficiency.

The study looked at 204 HIV-positive women, 89 percent of whom had vitamin D deficiency, who began taking antiretrovirals (ARVs) when their CD4 levels were below 200. Researchers found that, after two years of HIV therapy, vitamin D-deficient women had an average gain of 134 CD4s while those with adequate vitamin D levels gained 188 of the immune cells. Researchers determined that this difference was statistically significant and that it indicated low levels of vitamin D indeed have a negative effect on CD4 replenishment among women starting treatment late.

To read the aidsmap report, click here.

To read the study abstract, click here.

Search: HIV, low levels, vitamin D, CD4 cells , AIDS, aidsmap, increases, Women’s Interagency HIV Study, WIHS, women, deficiency, insufficient.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.